ICIceCure Medical Ltd ICCM · NASDAQ
$1.00 -7.41% (-$0.08)
- Market cap
- $2.43M
- Enterprise value
- -$9.51M
- P/E
- -
- Forward P/E
- -
- PEG
- -
- P/S
- 0.6x
- P/FCF
- -
- EV/EBITDA
- -
- ROIC
- -183.2%
- Gross margin
- 36.1%
- Net margin
- -427.7%
- Dividend yield
- -
- Payout ratio
- -
- Net debt/EBITDA
- -
- Beta
- 0.43
- Free float
- 77.0%
About the company
IceCure Medical Ltd (ICEC) is an Israeli company focused on medical technologies and innovative treatments. The company specializes in cryosurgery, a method of treatment that uses extremely low temperatures to destroy cancer cells. Its main product is the Cryoablation System, which offers a minimally invasive procedure and enables fast and effective treatment of tumors, including breast and kidney tumors. IceCure Medical is known for its innovative treatment solutions that can make a significant impact in oncology and other areas of medicine. IceCure Medical Ltd (ICEC) shares may be an attractive investment opportunity for investors interested in medical technologies and innovative treatments.
Sector
Healthcare
Industry
Medical - Devices
CEO
Eyal Shamir
Employees
68
Headquarters
Caesarea
Valuation
Is today's price reasonable?
Growth and estimates
Is it growing, and what comes next?
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
Financial health
Can it carry its debt?
Capital and dividends
What does the company do with the money it earns?
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number